Malignant neoplasm of breast in Brazilian women: A cross-sectional study from 2008 to 2019

Página do item simplificado
dc.contributorSistema FMUSP-HC: Faculdade de Medicina da Universidade de São Paulo (FMUSP) e Hospital das Clínicas da FMUSP
dc.contributor.authorJUSTO, Alberto Fernando O.
dc.contributor.authorCOLLACO, Rita de Cassia
dc.contributor.authorLESCANO, Caroline Honaiser
dc.contributor.authorOLIVEIRA, Ivan Pires de
dc.date.accessioned2024-02-15T14:54:16Z
dc.date.available2024-02-15T14:54:16Z
dc.date.issued2023
dc.description.abstractObjective: Breast cancer is the most lethal malignancy for women worldwide. Developed countries, such as Portugal, Spain, and the United States, have declining mortality rates due to breast cancer; however, in developing countries, the epidemiological reports are scarce. In this context, the aims of this study are to describe and discuss the female breast cancer profile of hospitalization and mortality according to age and geographic region in Brazil from 2008 to 2019.Methods: Data were obtained from the National Health System Department of Informatics (DATASUS), maintained by the Brazilian Ministry of Health, which includes the registers of hospitalization and mortality by malignant neoplasm of breast (code C50, ICD-10). Proportional rates of hospitalization and deaths were estimated per 100,000 inhabitants according to respective subjects' age, region, and year of the occurrence.Results: From 2008 to 2019, 643,822 hospital admissions due to malignant neoplasm of breast were reported in Brazil, of which the South and Southeast regions were the most prevalent. Higher hospitalization rates were seen in subjects aged 50-79-years-old. Regarding mortality, 53,480 deaths by breast cancer were reported; similarly to hospitalization, the Southeast and South were the most affected regions. Mortality rates have increased over time in different magnitudes depending on subjects' age.Conclusion: We have shown an increase in morbidity and mortality over time, which is dependent on patients' age and region. The results presented here may contribute to the ongoing discussion about the role and future perspectives of the Brazilian health care system, especially regarding to the strategies for the prevention, control, and treatment of breast cancer.eng
dc.description.indexMEDLINE
dc.description.indexPubMed
dc.description.indexWoS
dc.description.indexScopus
dc.description.sponsorshipSao Paulo Research Foundation (FAPESP) [2016/09539-8, 2017/26687-3, 2017/02201-4]
dc.description.sponsorshipCoordination for the Improvement of Higher Education Personnel (CAPES)
dc.identifier.citationJOURNAL OF THE NATIONAL MEDICAL ASSOCIATION, v.115, n.1, p.38-45, 2023
dc.identifier.doi10.1016/j.jnma.2022.12.003
dc.identifier.eissn1943-4693
dc.identifier.issn0027-9684
dc.identifier.urihttps://observatorio.fm.usp.br/handle/OPI/58118
dc.language.isoeng
dc.publisherNATL MED ASSOCeng
dc.relation.ispartofJournal of the National Medical Association
dc.rightsrestrictedAccesseng
dc.rights.holderCopyright NATL MED ASSOCeng
dc.subjectMalignant neoplasm of breasteng
dc.subjectDATASUSeng
dc.subjectHealth care systemeng
dc.subjectEpidemiologyeng
dc.subject.othercancer mortalityeng
dc.subject.otherriskeng
dc.subject.wosMedicine, General & Internaleng
dc.titleMalignant neoplasm of breast in Brazilian women: A cross-sectional study from 2008 to 2019eng
dc.typearticleeng
dc.type.categoryoriginal articleeng
dc.type.versionpublishedVersioneng
dspace.entity.typePublication
hcfmusp.author.externalCOLLACO, Rita de Cassia:Univ Campinas UNICAMP, Fac Med Sci, Dept Pharmacol, Campinas, Brazil
hcfmusp.author.externalLESCANO, Caroline Honaiser:Univ Campinas UNICAMP, Fac Med Sci, Dept Pharmacol, Campinas, Brazil
hcfmusp.author.externalOLIVEIRA, Ivan Pires de:Univ Fed Minas Gerais, Inst Agr Sci, Montes Claros, MG, Brazil
hcfmusp.citation.scopus0
hcfmusp.contributor.author-fmusphcALBERTO FERNANDO OLIVEIRA JUSTO
hcfmusp.description.beginpage38
hcfmusp.description.endpage45
hcfmusp.description.issue1
hcfmusp.description.volume115
hcfmusp.origemWOS
hcfmusp.origem.pubmed36577555
hcfmusp.origem.scopus2-s2.0-85146730816
hcfmusp.origem.wosWOS:001056055700001
hcfmusp.publisher.cityWASHINGONeng
hcfmusp.publisher.countryUSAeng
hcfmusp.relation.referenceAlvaro-Meca A, 2012, PUBLIC HEALTH, V126, P891, DOI 10.1016/j.puhe.2012.05.031eng
hcfmusp.relation.referenceAlwan A, 2010, LANCET, V376, P1861, DOI 10.1016/S0140-6736(10)61853-3eng
hcfmusp.relation.reference[Anonymous], 2008, Societade Brasileira de Mastologiaeng
hcfmusp.relation.referenceAquino EML, 2012, AM J EPIDEMIOL, V175, P315, DOI 10.1093/aje/kwr294eng
hcfmusp.relation.referenceBastos Joana, 2007, Acta Med Port, V20, P139eng
hcfmusp.relation.referenceBooth FW, 2012, COMPR PHYSIOL, V2, P1143, DOI 10.1002/cphy.c110025eng
hcfmusp.relation.referenceCaldas Flávio Augusto Ataliba, 2005, Radiol Bras, V38, P295, DOI 10.1590/S0100-39842005000400012eng
hcfmusp.relation.referenceKluthcovsky ACGC, 2014, REV ASSOC MED BRAS, V60, P387, DOI 10.1590/1806-9282.60.04.019eng
hcfmusp.relation.referencede Oliveira EXG, 2011, CIENC SAUDE COLETIVA, V16, P3649, DOI 10.1590/S1413-81232011001000002eng
hcfmusp.relation.referenceGrande R, 2003, Rev Ass Med Bras, V54, P23, DOI [10.1590/S0104-42302008000100016, DOI 10.1590/S0104-42302008000100016]eng
hcfmusp.relation.referenceIBGE, 2020, ABOUT USeng
hcfmusp.relation.referenceINCA, 2019, Ministry of Health recommendations for breast cancer screeningeng
hcfmusp.relation.referenceJacob L, 2020, J CANCER RES CLIN, V146, P1567, DOI 10.1007/s00432-020-03185-yeng
hcfmusp.relation.referenceKim SH, 2020, BREAST CANCER RES TR, V183, P697, DOI 10.1007/s10549-020-05811-2eng
hcfmusp.relation.referenceMa XR, 2020, J CELL PHYSIOL, V235, P4268, DOI 10.1002/jcp.29304eng
hcfmusp.relation.referenceMaskarinec G, 2019, CANCER EPIDEMIOL, V60, P179, DOI 10.1016/j.canep.2019.04.009eng
hcfmusp.relation.referenceMH, 2020, Estatisticas de cancereng
hcfmusp.relation.referenceNarod SA, 2015, J CANCER POLICY, V5, P8, DOI 10.1016/j.jcpo.2015.03.002eng
hcfmusp.relation.referencePaiva LD, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-39566-8eng
hcfmusp.relation.referencePierre-Victor D, 2020, CANCER EPIDEMIOL, V65, DOI 10.1016/j.canep.2020.101694eng
hcfmusp.relation.referencePoiseuil M, 2019, CANCER EPIDEMIOL, V60, P149, DOI 10.1016/j.canep.2019.03.016eng
hcfmusp.relation.referenceRojas K, 2016, CLIN OBSTET GYNECOL, V59, P651, DOI 10.1097/GRF.0000000000000239eng
hcfmusp.relation.referenceTanislav C, 2019, J CANCER RES CLIN, V145, P3047, DOI 10.1007/s00432-019-03022-xeng
hcfmusp.relation.referenceWang K, 2017, ONCOTARGET, V8, P81109, DOI 10.18632/oncotarget.20154eng
hcfmusp.relation.referenceWHO (World Health Organization), 2020, Child Maltreatmenteng
hcfmusp.relation.referenceZahnd WE, 2019, CANCER EPIDEMIOL, V63, DOI 10.1016/j.canep.2019.101624eng
hcfmusp.relation.referenceZhou WB, 2011, J CANCER RES CLIN, V137, P1053, DOI 10.1007/s00432-011-0979-zeng
hcfmusp.scopus.lastupdate2024-06-21
relation.isAuthorOfPublication2b7697cc-a550-49d8-9d38-0b28fb2fccae
relation.isAuthorOfPublication.latestForDiscovery2b7697cc-a550-49d8-9d38-0b28fb2fccae
Arquivos
Coleções
Artigos e Materiais de Revistas Científicas - FM/Outros
Artigos e Materiais de Revistas Científicas - LIM/22
Artigos e Materiais de Revistas Científicas - ODS/03